University of Texas MD Anderson Cancer Center.
Clin J Oncol Nurs. 2020 Oct 1;24(5):479-481. doi: 10.1188/20.CJON.479-481.
Phase 1 clinical trials are essential to improving outcomes in cancer care. The investigational agents in these trials may be associated with adverse events that can contribute to symptom burden and declining performance status for trial participants. The emerging role for oncology nurse practitioners (ONPs) as subinvestigators offers a unique practice setting for advanced practice nurses. In this role, ONPs provide expert oncology care, are responsible for swift recognition and management of adverse events, and ensure adherence to the clinical trial protocol.
阶段 1 临床试验对于改善癌症治疗结果至关重要。这些试验中的研究性药物可能与不良事件相关，这些不良事件可能导致试验参与者的症状负担和表现状态下降。肿瘤护士从业者 (ONP) 作为副研究者的新兴角色为高级实践护士提供了独特的实践环境。在这个角色中，ONP 提供专业的肿瘤护理，负责快速识别和管理不良事件，并确保遵守临床试验方案。
